A biomarker-guided first-in-human trial of subcutaneous ALM201 in patients with solid tumours.
Authors
El-Helali, APlummer, R
Jayson, Gordon C
Coyle, V.
Rogers, C
D'arcangelo, M
Graham, D
Drew, Y
Clamp, Andrew R
McCann, J
McCavigan, A
Knight, L
McCabe, N
Keating, K
Dyer, R
Harrison, T
Harkin, P
Robson, T
Kennedy, R
Wilson, R
Affiliation
Centre for Cancer Research and Cell Biology, Queen’s University Belfast, BelfastIssue Date
2016-10-01
Metadata
Show full item recordCitation
A biomarker-guided first-in-human trial of subcutaneous ALM201 in patients with solid tumours. 2016, 27(suppl 6):143TiP Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw363.91Additional Links
https://academic.oup.com/annonc/article/2798869/AType
Meetings and ProceedingsISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw363.91